Amino Acid Substitutions in the Hepatitis C Virus Core Region Are Associated With Postoperative Recurrence and Survival of Patients With HCV Genotype 1b-Associated Hepatocellular Carcinoma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Annals of Surgery

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e3182263b8ePMID 21709542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development.

  2010cited by this paper
• Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development

  2010cited by this paper
• Report of the 18th follow‐up survey of primary liver cancer in Japan

  2010cited by this paper
• Virological and Biochemical Features in Elderly HCV Patients with Hepatocellular Carcinoma: Amino Acid Substitutions in HCV Core Region as Predictor of Mortality after First Treatment

  2009cited by this paper
• Mutations in the Hepatitis C Virus core Gene Are Associated with Advanced Liver Disease and Hepatocellular Carcinoma

  2009cited by this paper
• Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study

  2009cited by this paper
• Epidemiology of hepatocellular carcinoma in Japan

  2009cited by this paper
• Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines

  2008cited by this paper
• Epidemiology of hepatocellular carcinoma in Japan

  2007cited by this paper
• Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

  2007cited by this paper
• Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis

  2007cited by this paper
• Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.

  2006cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

  2005cited by this paper
• Randomized clinical trial of long‐term outcome after resection of hepatitis C virus‐related hepatocellular carcinoma by postoperative interferon therapy

  2002cited by this paper
• Hepatocellular carcinoma: diagnosis and treatment.

  2002cited by this paper
• Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial.

  2001cited by this paper
• Des‐γ‐carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma

  2001cited by this paper
• Effects of Long-Term Postoperative Interferon- Therapy on Intrahepatic Recurrence after Resection of Hepatitis C VirusRelated Hepatocellular Carcinoma

  2001cited by this paper
• Serum levels of des‐γ‐carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma

  2000cited by this paper
• The fucosylation index of α‐fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma

  1998cited by this paper
• Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

  1998cited by this paper
• The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.

  1998cited by this paper
• Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.

  1998cited by this paper
• Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action

  1998cited by this paper
• Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

  1997cited by this paper
• New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

  1997cited by this paper
• Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.

  1994cited by this paper
• Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

  1994cited by this paper
• Possible multicentric occurrence of hepatocellular carcinoma: A clinicopathological study

  1994cited by this paper
• Establishment of assay kits for the determination of microheterogeneities of alpha-fetoprotein using lectin-affinity electrophoresis.

  1993cited by this paper
• Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis

  1991cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

  1973cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Genotypic Regulation of Type I Interferon Induction Pathways by Frameshift (F) Proteins of Hepatitis C Virus

  2020cites this paper
• Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study

  2017cites this paper
• Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma

  2017cites this paper
• Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.

  2017cites this paper
• Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients

  2016cites this paper
• A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.

  2015cites this paper
• Clinical Significance of Occult Hepatitis B Infection in Progression of Liver Disease and Carcinogenesis

  2013cites this paper
• Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma.

  2012cites this paper
• Effects of Antiviral Therapy on the Recurrence of Hepatocellular Carcinoma After Curative Resection or Liver Transplantation

  2012cites this paper
• Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma

  2012cites this paper
• Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology.

  2012cites this paper
• Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomy.

  2012cites this paper